Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : Australia hits vaccine milestone as Melbourne cases hover near record levels

09/23/2021 | 10:35pm EDT

* Australia passes 50% double-dose vaccine mark

* Two million doses administered in a week

* Seeing 'pleasing declines' in NSW cases

SYDNEY, Sept 24 (Reuters) - More than half of Australia's adult population were fully vaccinated against COVID-19 as of Friday, authorities said, as they step up inoculations in hopes of easing restrictions while cases linger near daily record levels in Victoria.

Australia is grappling with a third wave of infections from the highly infectious Delta variant that has led to lockdowns in its two largest cities, Sydney and Melbourne, and the capital, Canberra, affecting nearly half the country's 25 million people.

These tough curbs and a decision to shut construction sites for two weeks over the rapid spread of the virus among workers triggered anti-lockdown protests in Melbourne, Australia's second-largest city, during the week.

Police arrested more than 200 on Friday for theft, drug offences and breaching stay-at-home orders, authorities said, as small groups of protesters gathered throughout the afternoon at various locations.

As most of Australia's southeast remains under strict stay-at-home restrictions, virus-free Western Australia is gearing up to host the Australian Rules Football Grand Final for the first time, in front of 60,000 fans at Perth Stadium on Saturday.

Melbourne, which had hosted every Grand Final since 1898, was the sport's spiritual home until the pandemic forced a shift to Brisbane last year.

Victoria on Friday reported one new death and 733 new infections, its second biggest daily rise in the pandemic, down from the record high of 766 on Thursday. Most cases were detected in Melbourne.

Both New South Wales (NSW) and Victorian leaders have pledged more freedom to residents once full vaccinations in people older than 16 reach 70%, expected next month. So far, 57% have been fully vaccinated in NSW, above the national average of 50.1%. Two million doses were administered in country in the last seven days.

Daily cases may have stabilised in NSW, the epicentre of the country's worst outbreak, as it reported 1,043 new infections, down from 1,063 on Thursday.

"We are seeing pleasing declines ... hopefully we will see numbers decrease in coming days and weeks," state Chief Health Officer Kerry Chant said during a media briefing in Sydney.

But officials flagged any easing of curbs in NSW would be done "cautiously and moderately" when the state hits its 70% dual-dose target, around Oct. 6, to avoid spikes in cases that could overwhelm its health systems.

Even with the fast-moving Delta outbreak, Australia has largely avoided high numbers seen in many comparable countries, with some 94,000 cases and 1,208 deaths, and the death rate is lower than last year because of higher vaccination rates. (Reporting by Renju Jose; Editing by Gerry Doyle and Tom Hogue)

ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -0.22% 8795 Delayed Quote.20.08%
MODERNA, INC. -2.31% 324.21 Delayed Quote.210.34%
All news about ASTRAZENECA PLC
07:22aASTRAZENECA : Imfinzi plus tremelimumab significantly improved overall survival in HIMALAY..
06:27aGT CAPITAL : Donates 3,000 COVID-19 Vaccine Doses to Government of Makati, Philippines
06:06aASTRAZENECA : JP Morgan remains its Buy rating
05:50aAstraZeneca Says Study in Liver Cancer Meets Objective
05:46aASTRAZENECA : UBS remains its Buy rating
04:50aASTRAZENECA : Says Phase 3 Trial of Potential Imfinzi-Tremelimumab Combination Therapy Mee..
04:44aASTRAZENECA : Japan to Donate Almost 2 Million AstraZeneca COVID-19 Shots to Philippines
03:39aCSL : Reaffirms Commitment to Manufacture 50 Million Doses of AstraZeneca Vaccine
02:21aASTRAZENECA : Liver Cancer Combo Therapy Improves Patient Survival in Late-Stage Study
02:12aASTRAZENECA : Imfinzi plus tremelimumab significantly improved overall survival in HIMALAY..
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 590 M - -
Net income 2021 4 919 M - -
Net Debt 2021 24 667 M - -
P/E ratio 2021 34,5x
Yield 2021 2,33%
Capitalization 187 B 187 B -
EV / Sales 2021 5,96x
EV / Sales 2022 4,84x
Nbr of Employees 76 100
Free-Float 96,4%
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 27
Last Close Price 120,92 $
Average target price 138,73 $
Spread / Average Target 14,7%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC20.08%186 771
JOHNSON & JOHNSON2.49%421 487
ROCHE HOLDING AG15.58%336 383
PFIZER, INC.13.20%233 631
NOVO NORDISK A/S51.58%230 493